News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
458,017 Results
Type
Article (32423)
Company Profile (227)
Press Release (425367)
Section
Business (140291)
Career Advice (1334)
Deals (26264)
Drug Delivery (103)
Drug Development (59770)
Employer Resources (153)
FDA (9695)
Job Trends (10870)
News (240752)
Policy (21799)
Tag
Academia (1791)
Alliances (37451)
Alzheimer's disease (899)
Approvals (9649)
Artificial intelligence (114)
Bankruptcy (223)
Best Places to Work (8090)
Biosimilars (74)
Biotechnology (119)
Cancer (746)
Cardiovascular disease (76)
Career advice (1122)
Cell therapy (147)
Clinical research (48074)
Collaboration (312)
Compensation (102)
COVID-19 (1583)
C-suite (82)
Data (810)
Diabetes (117)
Diagnostics (3655)
Drug pricing (96)
Earnings (48088)
Employer resources (133)
Events (68576)
Executive appointments (271)
FDA (10032)
Funding (265)
Gene therapy (121)
GLP-1 (568)
Government (2595)
Healthcare (9874)
Infectious disease (1648)
Inflammatory bowel disease (85)
Interviews (197)
IPO (11616)
Job creations (3053)
Job search strategy (989)
Layoffs (304)
Legal (5128)
Lung cancer (124)
Manufacturing (157)
Medical device (5235)
Medtech (5240)
Mergers & acquisitions (14767)
Metabolic disorders (373)
Neuroscience (1115)
NextGen Class of 2024 (3900)
Non-profit (2242)
Northern California (975)
Obesity (230)
Opinion (193)
Patents (80)
People (44895)
Pharmaceutical (91)
Phase I (14935)
Phase II (20574)
Phase III (16319)
Pipeline (341)
Policy (79)
Postmarket research (1891)
Preclinical (6024)
Radiopharmaceuticals (183)
Rare diseases (170)
Real estate (4603)
Regulatory (14971)
Research institute (1713)
Resumes & cover letters (203)
Southern California (849)
Startups (3013)
United States (8971)
Vaccines (317)
Weight loss (195)
Date
Last 7 days (469)
Last 30 days (2328)
Last 365 days (25321)
2024 (23192)
2023 (28058)
2022 (35443)
2021 (38161)
2020 (36026)
2019 (30014)
2018 (22867)
2017 (23485)
2016 (22518)
2015 (26231)
2014 (20496)
2013 (17318)
2012 (18567)
2011 (18949)
2010 (17811)
Location
Africa (561)
Arizona (99)
Asia (30528)
Australia (4344)
California (2177)
Canada (959)
China (176)
Colorado (103)
Connecticut (93)
Europe (64059)
Florida (311)
Illinois (216)
Indiana (150)
Maryland (322)
Massachusetts (1737)
Michigan (131)
Minnesota (163)
New Jersey (745)
New York (694)
North Carolina (554)
Northern California (975)
Ohio (97)
Pennsylvania (493)
South America (803)
Southern California (849)
Texas (302)
Washington State (216)
458,017 Results for "exela pharma sciences llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
January 10, 2024
·
1 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
October 2, 2024
·
8 min read
Press Releases
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
November 11, 2024
·
8 min read
FSD Pharma Provides Corporate Update - May 24, 2024
FSD Pharma Inc. is pleased to announce that it has entered into an investor relations services agreement with IR Agency LLC effective May 22, 2024.
May 24, 2024
·
7 min read
Press Releases
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 19, 2024
·
6 min read
1 of 45,802
Next
